RMCM
ARRY

Reynders McVeigh Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Reynders McVeigh Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,900
Closed -$273K – 233
2019
Q2 		$273K Buy
+5,900
New +$166K 0.03% 191

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Reynders McVeigh Capital Management's ARRY Position: Q3 2019 in Review

Reynders McVeigh Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 5,900 shares — an estimated $273K sold.

Reynders McVeigh Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $273K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Reynders McVeigh Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 5,900 Array Biopharma Inc shares in Q3 2019, an estimated $273K.
  • Reynders McVeigh Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Reynders McVeigh Capital Management's Array Biopharma Inc position peaked at $273K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.